316 related articles for article (PubMed ID: 31437584)
1. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins.
Morel B; Conejero-Lara F
Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140264. PubMed ID: 31437584
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins.
Murphy RM
Biochim Biophys Acta; 2007 Aug; 1768(8):1923-34. PubMed ID: 17292851
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
Ghosh P; Kumar A; Datta B; Rangachari V
BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation.
Bhak G; Choe YJ; Paik SR
BMB Rep; 2009 Sep; 42(9):541-51. PubMed ID: 19788854
[TBL] [Abstract][Full Text] [Related]
5. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
6. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
7. Structural, morphological, and functional diversity of amyloid oligomers.
Breydo L; Uversky VN
FEBS Lett; 2015 Sep; 589(19 Pt A):2640-8. PubMed ID: 26188543
[TBL] [Abstract][Full Text] [Related]
8. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
[TBL] [Abstract][Full Text] [Related]
10. Revisiting supersaturation as a factor determining amyloid fibrillation.
So M; Hall D; Goto Y
Curr Opin Struct Biol; 2016 Feb; 36():32-9. PubMed ID: 26774801
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
12. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
13. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
Stefani M
Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
[TBL] [Abstract][Full Text] [Related]
14. Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation.
Cao Y; Tang X; Yuan M; Han W
Prog Mol Biol Transl Sci; 2020; 170():461-504. PubMed ID: 32145951
[TBL] [Abstract][Full Text] [Related]
15. The role of amyloids in Alzheimer's and Parkinson's diseases.
Salahuddin P; Fatima MT; Uversky VN; Khan RH; Islam Z; Furkan M
Int J Biol Macromol; 2021 Nov; 190():44-55. PubMed ID: 34480905
[TBL] [Abstract][Full Text] [Related]
16. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
17. Aβ Oligomer Dissociation Is Catalyzed by Fibril Surfaces.
Dear AJ; Thacker D; Wennmalm S; Ortigosa-Pascual L; Andrzejewska EA; Meisl G; Linse S; Knowles TPJ
ACS Chem Neurosci; 2024 Jun; 15(11):2296-2307. PubMed ID: 38785363
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
19. Secondary nucleation in amyloid formation.
Törnquist M; Michaels TCT; Sanagavarapu K; Yang X; Meisl G; Cohen SIA; Knowles TPJ; Linse S
Chem Commun (Camb); 2018 Aug; 54(63):8667-8684. PubMed ID: 29978862
[TBL] [Abstract][Full Text] [Related]
20. Insulin and Lispro Insulin: What is Common and Different in their Behavior?
Selivanova OM; Suvorina MY; Surin AK; Dovidchenko NV; Galzitskaya OV
Curr Protein Pept Sci; 2017; 18(1):57-64. PubMed ID: 27226198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]